Abnoba

Abnoba GmbH is a long-established, private German biopharmaceutical company with a singular focus on mistletoe-based supportive cancer care. The company leverages over 50 years of experience in producing standardized mistletoe extracts (abnobaVISCUM) aimed at improving patients' immune response and quality of life during and after surgery, chemotherapy, and radiotherapy. It operates as a commercial-stage entity, generating revenue from its approved products, which are primarily marketed in German-speaking and select European countries. Abnoba's strategy is built on deep expertise in phytopharmaceuticals, ongoing clinical research, and educating healthcare professionals and patients on integrative oncology.

Standardized cultivation, harvesting, and extraction of European mistletoe (Viscum album L.) from specific host trees (e.g., apple, oak, pine) to produce immunomodulatory phytopharmaceutical extracts for supportive cancer care.

Abnoba competes directly with other European manufacturers of injectable mistletoe extracts, such as Iscador (Weleda) and Helixor. The broader competitive set includes all pharmaceutical and nutraceutical products aimed at cancer supportive care (e.g., antiemetics, growth factors) and the wider field of complementary and alternative medicine (CAM) in oncology.